Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 2/24/16 → 2/23/18 |
Funding
- Galera Therapeutics Incorporated: $23,355.00
15-28-HN-28-GT (GT-201): A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Effects of Intravenous GC4419 on the Incidence and Duration of Severe Oral Mucositis (OM) in Patients Receiving Post-Operative or Definitive Therapy
- Kudrimoti, Mahesh (PI)
- Arnold, Susanne (CoI)
- St Clair, William (CoI)
- Thind, Ravneet (CoI)